The most effective way to protect yourself from gonorrhea is using condoms or dental dams every time you have vaginal, anal, or oral sex. But condoms are just one layer of defense. A combination of barrier protection, regular testing, open conversations with partners, and newer prevention options like post-exposure antibiotics gives you the strongest shield against infection.
Gonorrhea spreads through contact with infected mucous membranes during vaginal, anal, or oral sex. It can infect the genitals, rectum, and throat, and roughly 45% of all gonorrhea cases never produce symptoms. That means you or a partner could carry and transmit the infection without knowing it, which is exactly why prevention requires more than just watching for warning signs.
How Condoms Reduce Your Risk
Condoms remain the most accessible and well-studied barrier against gonorrhea. Studies show they reduce the risk of gonorrhea by 49% to 75%, depending on how consistently they’re used. That’s a meaningful reduction, but it’s not airtight. The gap exists because condoms don’t cover every surface that can harbor the bacteria. Gonorrhea in the throat or rectum, for example, can spread through oral sex where condoms are used less often.
For oral sex on a vulva or anus, dental dams provide a barrier, though they’re used far less frequently in practice. Internal (sometimes called “female”) condoms are another option for vaginal or anal sex and offer similar protection. The key factor across all barrier methods isn’t the type you choose. It’s whether you use one every time, from start to finish. Inconsistent use dramatically narrows the protection gap.
Why Testing Matters More Than Symptoms
Because nearly half of gonorrhea infections cause no noticeable symptoms, relying on how you or your partner feels is unreliable. Someone with a throat infection from oral sex, for instance, will almost never have symptoms. Rectal infections are also frequently silent. This makes routine screening one of the most powerful prevention tools available.
The CDC recommends annual gonorrhea screening for all sexually active women under 25 and for older women with risk factors like new or multiple partners. People living with HIV should be screened at their first evaluation and at least once a year after that, with more frequent testing if their sexual activity warrants it. Men who have sex with men benefit from screening every three to six months depending on the number of partners. If you’ve been treated for gonorrhea, get retested three months later, because reinfection is common.
Testing typically involves a urine sample or a swab of the throat, genitals, or rectum depending on the type of sex you’re having. If you only test urine but regularly have oral or anal sex, infections at those sites will be missed entirely. Be specific with your provider about where you need to be tested.
Talking to Partners About Testing
Asking a new partner to get tested before you become intimate is one of the simplest and most effective prevention steps. Harvard Health suggests bringing it up during a private, nonsexual moment and framing it as something you’re doing proactively for both of your health, not as an accusation. You can suggest getting tested together at a clinic, urgent care center, or pharmacy, or testing separately and sharing results beforehand.
This conversation also opens the door to discussing what kinds of sex you’re each comfortable with, what barriers you’ll use, and whether either of you has had a recent STI. None of this has to be awkward if you treat it as a normal part of starting a sexual relationship, which it is.
Fewer Partners, Lower Exposure
Every new sexual partner represents a new potential exposure. That’s not a moral judgment; it’s math. Reducing your number of concurrent partners, or having sex within a mutually monogamous relationship where both people have tested negative, significantly lowers your odds. If monogamy isn’t your situation, combining fewer partners with consistent condom use and regular testing creates a practical risk-reduction strategy.
Post-Exposure Antibiotics for High-Risk Groups
A newer prevention option called doxy-PEP (doxycycline post-exposure prophylaxis) is now recommended by the CDC for specific populations. In three large clinical trials, taking 200 mg of doxycycline within 72 hours after sex reduced gonorrhea infections by approximately 50% and reduced syphilis and chlamydia infections by more than 70%.
The CDC currently recommends doxy-PEP for men who have sex with men and transgender women who have had at least one bacterial STI (gonorrhea, chlamydia, or syphilis) diagnosed in the past 12 months. It’s taken as a single 200 mg dose after a sexual encounter, not exceeding one dose per 24 hours. This isn’t a blanket recommendation for everyone. It’s a targeted tool for people at elevated risk, prescribed through a shared decision-making conversation with a healthcare provider.
For cisgender women, the evidence is less clear, and the CDC hasn’t extended the recommendation to this group yet.
Mouthwash and Throat Infections
Pharyngeal (throat) gonorrhea is one of the harder forms to prevent because condoms are used inconsistently during oral sex. A small but interesting randomized trial found that gargling with alcohol-containing Listerine for one minute significantly reduced the amount of gonorrhea bacteria on the throat surface. Among participants with pharyngeal gonorrhea, 52% of those who gargled Listerine still tested positive by culture afterward, compared to 84% in the saline (salt water) group.
This doesn’t mean mouthwash prevents infection outright. The study was small and looked at reducing bacterial load rather than preventing new infections. But gargling with antiseptic mouthwash after oral sex is low-cost, low-risk, and may offer a modest additional layer of protection while larger studies continue.
Making Sure Partners Get Treated
If you do test positive for gonorrhea, one of the most important things you can do to protect yourself going forward is ensuring your recent sexual partners get treated. Without treatment, a partner can simply reinfect you. Expedited partner therapy allows your provider to give you a prescription or medication to pass directly to your partner, even if that partner hasn’t been examined. This is legal in most U.S. states and is specifically designed to break the cycle of reinfection that’s common with gonorrhea and chlamydia.
Why Prevention Is Becoming More Urgent
Gonorrhea is growing harder to treat. About 35% of tested samples each year show resistance to ciprofloxacin, an antibiotic that was once a go-to treatment. Resistance to azithromycin peaked at nearly 6% in 2020. The antibiotics that still work reliably, particularly ceftriaxone, remain effective for now, with resistance rates below 0.1%. But the trend line is concerning, and health authorities have flagged gonorrhea as one of the most urgent antibiotic resistance threats. Every infection that’s prevented is one less opportunity for the bacteria to evolve further resistance.
There is currently no licensed vaccine for gonorrhea, though a meningitis B vaccine has shown roughly 32% effectiveness against gonorrhea in observational studies. That’s modest, and a randomized controlled trial didn’t confirm the benefit. A dedicated gonorrhea vaccine remains years away, which makes the prevention strategies above your best and most reliable options.